Health Care Equipment & Services

Insider buying of InspireMD shares signals confidence in its acute myocardial infarction device, with Stuka Paul’s $0.88 purchase hinting at future upside.

ElectroCore CFO’s 3,000‑share sale is a routine, tax‑related move that won’t shift stock sentiment. Focus on leadership buying, clinical milestones, and market growth.

Insider CFO buy at $0.12 signals confidence in Inspira Technologies Oxy BHN’s respiratory‑support launch, amid volatile shares and a strategic hedging plan.

Orthofix Medical Inc. sees Juniper Investment Company hold 3.2 m shares, showing long‑term confidence amid a negative P/E, governance scrutiny, and market volatility.

UHS insider activity: Alan Miller’s trust transfers keep family control strong, yet market impact is minimal—no immediate price change expected.

Insider buying surge at Streamex Corp. signals confidence in its tokenised liquidity and cardiac tech, but investors face high‑beta risk and revenue volatility.

JW Asset Management’s recent sale of 25,320 ELHC shares signals a disciplined portfolio shift, not a warning of weak fundamentals—insider moves, year‑to‑date growth, and strong cash flow keep Elh Holding’s silicone‑implant business poised for contin…

Tenet Healthcare insider trades show board confidence and long‑term upside, while the company’s low P/E offers a value play for investors seeking growth and stability.

CEO Bailey David F’s insider buying amid a 99 % share plunge signals cautious confidence, yet investors should weigh this move against the company’s tech‑driven turnaround plan and changing healthcare reimbursement models.

Analyze Clover Health’s insider sales—structured 10b‑5‑1 trades, volume, price timing, and market impact—while assessing valuation, liquidity, and tech‑driven growth prospects for investors.